SILO PHARMA, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SILO PHARMA, INC. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $1.23M, a 26.61% decline year-over-year.
- SILO PHARMA, INC. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $1.74M.
- SILO PHARMA, INC. stock issued during period, value, new issues for the quarter ending 2024-06-30 was $1.67M.
- SILO PHARMA, INC. stock issued during period, value, new issues for the quarter ending 2022-09-30 was $4.94M.
- SILO PHARMA, INC. stock issued during period, value, new issues for fiscal 2024 was $1.74M.
- SILO PHARMA, INC. stock issued during period, value, new issues for fiscal 2022 was $4.94M.
- SILO PHARMA, INC. stock issued during period, value, new issues for fiscal 2020 was $2.12M.
- SILO PHARMA, INC. stock issued during period, value, new issues for fiscal 2018 was $24.50K.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $3.36M POS AM · filed 2026-04-14 | |
| 2025-06-30 | $1.23M 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $1.74M 10-K · filed 2025-03-28 | |
| 2024-09-30 | $1.74M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $1.67M 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $4.94M 10-K · filed 2024-03-25 | |
| 2022-09-30 | $4.94M 10-Q · filed 2023-11-13 | |
| 2020-12-31 | $2.12M 10-K · filed 2022-03-28 | |
| 2020-06-30 | $2.12M 10-Q · filed 2021-11-10 | |
| 2018-12-31 | $24.50K 10-K · filed 2020-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |